SALES ALERT: Unlock 10-40% Off on All Cell Products!

Human Pancreatic Stellate Cells (HPSC)

SKU: 10HU-211

Human Pancreatic Stellate Cells (HPSC)

SKU: 10HU-211
Pricing Starting at

Starting at: $927.00

Available Options

SKUPackage SizePriceQuantityAdd to Cart
10HU-211Cryopreserved, 0.5 million cells/vialStarting at: $927.00

Associated Products


Product Description

Human Pancreatic Stellate Cells (HPSC) are the main fibroblastic cells of the pancreas. HPSC are responsible for the synthesis and the degradation of the extracellular matrix proteins that promote tissue repair. They are found adjacent to pancreatic acinar cells and around small pancreatic ducts and blood vessels. When HPSC are activated, they assume myofibroblast-like morphology and secrete excessive amounts of extracellular matrix proteins, which can lead to desmoplasia in chronic pancreatitis and adenocarcinoma [1,2]. Recent studies have shown that HPSC can also act as progenitor cells, immune cells, and intermediaries in exocrine pancreatic secretion [3]. Additionally, HPSC stimulate pancreatic cancer proliferation, inhibit apoptosis, and enhance angiogenesis [2]. HPSC are the ideal model for studying pancreatic tumor formation and they can be used to develop novel therapies for treatment of chronic pancreatitis and adenocarcinoma.

iXCells Biotechnologies offers HPSC from human pancreas. HPSC are cryopreserved after purification and delivered frozen. Each vial contains >5 x 105 cells in 1 ml volume. HPSC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HPSC can be further expanded for no more than 3 passages in Stellate Cell Growth Medium (Cat# MD-0014). Further expansion may decrease the purity.

Human Pancreatic Stellate Cells

Figure1. Phase contrast image of Human Pancreatic Stellate Cells (HPSC) at DIV1.

Product Details

Tissue Human pancreas
Package Size 0.5 million cells/vial
Passage Number P2
Shipped Cryopreserved
Storage Liquid nitrogen
Growth Properties Adherent
Media Stellate Cell Growth Medium (Cat# MD-0014)


[1] Erkan, M., Hausmann, S., Michalski, C., Schlitter, M., Fingerle, A,. Friess, H., and Kleeff, J. (2012). “How fibrosis influences imaging and surgical decision in pancreatic cancer”. Front. Physio. 3:389.

[2] Apte, M., Pirola, R., and Wilson, J. (2012). “Pancreatic stellate sells: A starring role in normal and diseased pancreas”. Front. Physio. 3:344.

[3] Mato, E., Lucas, M., Petriz, J., Gomis, R., and Novials, A. (2009). “Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas”. Biochem. J. 421:181.


Download Datasheet

Manuals & Protocols

  • Li, Y., Zhao, Z., Lin, C., Liu, Y., Staveley-OCarroll, K. F., Li, G., & Cheng, K. (2021). Silencing PCBP2 NORMALIZES Desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. Theranostics, 11(5), 2182-2200. doi:10.7150/thno.53102 -- Learn More

  • Li, Y., Zhao, Z., Liu, H., Fetse, J. P., Jain, A., Lin, C., & Cheng, K. (2019). Development of a Tumor-Responsive Nanopolyplex Targeting pancreatic cancer cells and Stroma. ACS Applied Materials & Interfaces, 11(49), 45390-45403. doi:10.1021/acsami.9b15116 -- Learn More